PRJNA525087
Mapping Genetic Modifiers of Radiation-Induced Cardiotoxicity to Rat Chromosome 3
Radiation therapy is used in ~50% of cancer patients to reduce the risk of recurrence and in some cases improve survival. Despite these benefits, doses can be limited by toxicity in multiple organs, including the heart. The underlying causes and biomarkers of radiation-induced cardiotoxicity are currently unknown, prompting the need for experimental models with inherent differences in sensitivity and resistance to the development of radiation-induced cardiotoxicity. We have identified the parental SS (Dahl salt sensitive/Mcwi) rat strain to be a highly-sensitized model of radiation-induced cardiotoxicity. In comparison, substitution of rat chromosome 3 from the resistant BN (Brown Norway) rat strain onto the SS background (SS-3BN consomic) significantly attenuated radiation-induced cardiotoxicity. RNA-sequencing (RNA-seq) was used for prioritizing the list of potential candidates, which nominated multiple genes and pathways that were differentially expressed in the left ventricles of SS and SS-3BN rats after radiation.